As of November 2024, Aptose Biosciences has a market cap of $3.15M. This makes Aptose Biosciences the world's 35353th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $15.96M | -20.87% |
2023 | $20.17M | -70.80% |
2022 | $69.10M | -57.04% |
2021 | $160.83M | -69.18% |
2020 | $521.81M | -22.75% |
2019 | $675.50M | 196.86% |
2018 | $227.55M | -14.73% |
2017 | $266.86M | 61.15% |
2016 | $165.60M | -45.06% |
2015 | $301.41M | -57.48% |
2014 | $708.86M | -4.89% |
2013 | $745.26M | 71.48% |
2012 | $434.61M | 64.77% |
2011 | $263.77M | -81.91% |
2010 | $1.46B | -39.29% |
2009 | $2.40B | 80.65% |
2008 | $1.33B | -82.79% |
2007 | $7.72B | -18.14% |
2006 | $9.44B | -12.00% |
2005 | $10.72B | -58.33% |
2004 | $25.73B | -21.05% |
2003 | $32.60B | 130.30% |
2002 | $14.15B | -58.75% |
2001 | $34.31B | -30.81% |
2000 | $49.59B | 29.92% |
1999 | $38.17B | 456.25% |
1998 | $6.86B | -71.56% |
1997 | $24.12B | -25.00% |
1996 | $32.17B | 33.33% |
1995 | $24.12B | -40.98% |
1994 | $40.88B | -56.43% |
1993 | $93.82B | -43.09% |
1992 | $164.85B | 384275.00% |
1970 | $42.89M | - |